Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Subscribe to see Biora Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Biora Therapeutics is a biotechnology company headquartered in United States. It has raised at least $4M across the 5 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Debt, raised $4M in September 2024. Xcout tracks 1 named person at Biora Therapeutics, including Eric d'Esparbes (Chief Financial Officer).
As of 16 November 2026. Source: Xcout Intel.
At least $4M raised across the 5 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt | $4M | 1 named | |
| Series C - II | Undisclosed | — | |
| Series C | Undisclosed | — | |
| Series B - II | Undisclosed | — | |
| Debt | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 2 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Biora Therapeutics's closest competitors — see the full list of competitors and alternatives →
Applied Molecular Transport was a United States biotechnology company that developed oral biologic medicines using a proprietary epithelial drug-delivery platform. Its programs targeted gastrointestinal and autoimmune diseases, serving patients with conditions such as inflammatory bowel disease.
Hera Health Solutions, Inc. is a biotechnology company founded in 2017 and headquartered in Memphis, Tennessee. The firm focuses on revolutionizing how medicines are delivered to improve global healthcare access.
Exa Biosciences builds infrastructure solutions designed to power the development of next-generation therapeutic biologics. The company provides foundational support and technologies tailored for organizations and researchers working in the biotherapeutic sector.
Surf Bio, Inc. is a biotechnology company that collaborates with multinational pharmaceutical firms on drug delivery technologies and therapeutic pipelines.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Terrestrial Bio is a biotechnology company headquartered in Woburn, Massachusetts, that features a MAP platform designed to support peptides, proteins, vaccines, and combination products. The company is expanding its operations with a world-class manufacturing facility and headquarters.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Biora Therapeutics? Suggest a correction · Work at Biora Therapeutics? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.